Pfizer’s campaign to promote Lyrica is part of a stepped-up arms race among Western drug makers for a bigger presence in Japan, the world’s second-largest pharmaceuticals market after the U.S., with about $100 billion in yearly sales.
The Wall Street Journal
posted 30 September, 2011by jsantilli
Established in 1989, Knowledge Source provides healthcare information, synthesis, analyses and presentation services through market research reports and custom research.
Follow on Twitter
Scaffold theme by Mike Harding.